RXO

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 1.43 B1.42 B1.42 B1.47 B1.43 B1.77 B 6.09 B Gross profit 280 M301 M284 M266 M254 M302 M 1.11 B Operating expenses 224 M231 M229 M297 M208 M223 M 957 M Selling/general/admin expenses 210 M214 M208 M200 M197 M211 M 816 M Research & development —————— — Operating income -30 M0-7 M-42 M-28 M1 M -76 M Non-Operating Income, Total 0-2 M1 M1 M-1 M0 1 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 000000 0 Unusual income/expense 0-2 M1 M1 M-1 M0 1 M Pretax income -39 M-10 M-15 M-51 M-49 M-8 M -123 M Equity in earnings —————— — Taxes -8 M-1 M-1 M-5 M-13 M1 M -18 M Non-controlling/minority interest —————— — After tax other income/expense -2 M-4 M-1 M-4 M-2 M-3 M -10 M Net income before discontinued operations -31 M-9 M-14 M-46 M-36 M-9 M -105 M Discontinued operations —————— — Net income -31 M-9 M-14 M-46 M-36 M-9 M -105 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -31 M-9 M-14 M-46 M-36 M-9 M -105 M Basic earnings per share (Basic EPS) -0.18-0.05-0.08-0.28-0.21-0.05 -0.62 Diluted earnings per share (Diluted EPS) -0.18-0.05-0.08-0.28-0.21-0.05 -0.62 Average basic shares outstanding 168.02 M168.53 M168.58 M168.46 M169.1 M169.65 M — Diluted shares outstanding 168.02 M168.53 M168.58 M168.46 M169.1 M169.65 M — EBITDA 88 M100 M81 M-3 M72 M105 M 255 M EBIT 56 M70 M55 M-31 M46 M79 M 149 M Cost of revenue 1.15 B1.12 B1.14 B1.2 B1.17 B1.47 B 4.98 B Other cost of goods sold 1.15 B1.12 B1.14 B1.2 B1.17 B1.47 B 4.98 B Depreciation & amortization (cash flow) 32 M30 M26 M28 M26 M26 M 106 M